Dou S - Search Results

1

ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.

Dou S, Yang XZ, Xiong MH, Sun CY, Yao YD, Zhu YH, Wang J. Dou S, et al. Adv Healthc Mater. 2014 Nov;3(11):1792-803. doi: 10.1002/adhm.201400037. Epub 2014 Jun 20. Adv Healthc Mater. 2014. PMID: 24947820

2

Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression.

Sun TM, Du JZ, Yao YD, Mao CQ, Dou S, Huang SY, Zhang PZ, Leong KW, Song EW, Wang J. Sun TM, et al. Among authors: dou s. ACS Nano. 2011 Feb 22;5(2):1483-94. doi: 10.1021/nn103349h. Epub 2011 Jan 4. ACS Nano. 2011. PMID: 21204585

3

Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells.

Wang F, Wang YC, Dou S, Xiong MH, Sun TM, Wang J. Wang F, et al. Among authors: dou s. ACS Nano. 2011 May 24;5(5):3679-92. doi: 10.1021/nn200007z. Epub 2011 Apr 12. ACS Nano. 2011. PMID: 21462992

4

Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.

Yang XZ, Dou S, Sun TM, Mao CQ, Wang HX, Wang J. Yang XZ, et al. Among authors: dou s. J Control Release. 2011 Dec 10;156(2):203-11. doi: 10.1016/j.jconrel.2011.07.035. Epub 2011 Aug 1. J Control Release. 2011. PMID: 21839126

5

Sheddable ternary nanoparticles for tumor acidity-targeted siRNA delivery.

Yang XZ, Du JZ, Dou S, Mao CQ, Long HY, Wang J. Yang XZ, et al. Among authors: dou s. ACS Nano. 2012 Jan 24;6(1):771-81. doi: 10.1021/nn204240b. Epub 2011 Dec 9. ACS Nano. 2012. PMID: 22136582

6

Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.

Yang XZ, Dou S, Wang YC, Long HY, Xiong MH, Mao CQ, Yao YD, Wang J. Yang XZ, et al. Among authors: dou s. ACS Nano. 2012 Jun 26;6(6):4955-65. doi: 10.1021/nn300500u. Epub 2012 Jun 5. ACS Nano. 2012. PMID: 22646867

7

Anti-Her2 single-chain antibody mediated DNMTs-siRNA delivery for targeted breast cancer therapy.

Dou S, Yao YD, Yang XZ, Sun TM, Mao CQ, Song EW, Wang J. Dou S, et al. J Control Release. 2012 Aug 10;161(3):875-83. doi: 10.1016/j.jconrel.2012.05.015. Epub 2012 May 14. J Control Release. 2012. PMID: 22762887

8

Doxorubicin conjugate of poly(ethylene glycol)-block-polyphosphoester for cancer therapy.

Sun CY, Dou S, Du JZ, Yang XZ, Li YP, Wang J. Sun CY, et al. Among authors: dou s. Adv Healthc Mater. 2014 Feb;3(2):261-72. doi: 10.1002/adhm.201300091. Epub 2013 Jul 15. Adv Healthc Mater. 2014. PMID: 23852934

9

Synthetic lethal therapy for KRAS mutant non-small-cell lung carcinoma with nanoparticle-mediated CDK4 siRNA delivery.

Mao CQ, Xiong MH, Liu Y, Shen S, Du XJ, Yang XZ, Dou S, Zhang PZ, Wang J. Mao CQ, et al. Among authors: dou s. Mol Ther. 2014 May;22(5):964-73. doi: 10.1038/mt.2014.18. Epub 2014 Feb 5. Mol Ther. 2014. PMID: 24496383 Free PMC article.

10

Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles.

Liu Y, Zhu YH, Mao CQ, Dou S, Shen S, Tan ZB, Wang J. Liu Y, et al. Among authors: dou s. J Control Release. 2014 Oct 28;192:114-21. doi: 10.1016/j.jconrel.2014.07.001. Epub 2014 Jul 10. J Control Release. 2014. PMID: 25016158

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,026 results

Search Page

Filters